3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
12
Head and Neck Neoplasms
3
Condylomata Acuminata
3
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Exanthema
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Wounds and Injuries
1
Warts
1
Virus Diseases
1
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Radiodermatitis
1
Parapsoriasis
1
Papillomavirus Infections
1
Non-Muscle Invasive Bladder Neoplasms
1
Non-Melanoma Skin Cancers
1
Lymphoma, Follicular
1
Keratosis, Seborrheic
1
Hypogonadism
1
Hemangioma, Cavernous
1
Hemangioma
1
Interventions
Cisplatin
55
Carboplatin
50
pembrolizumab
42
Paclitaxel
42
Gemcitabine
28
Pemetrexed
23
Radiotherapy
21
Magnetic Resonance Spectroscopy
20
Radiotherapy, Intensity-Modulated
18
Docetaxel
17
Cetuximab
17
Specimen Handling
16
Nivolumab
16
Fluorouracil
16
Cyclophosphamide
14
durvalumab
13
Bevacizumab
12
Radiation
11
130-nm albumin-bound paclitaxel
11
Sorafenib
10
Platinum
10
1,2-diaminocyclohexaneplatinum II citrate
10
osimertinib
9
Sunitinib
8
Oxaliplatin
8
Irinotecan
8
Ipilimumab
8
Everolimus
8
Drug Therapy
8
Capecitabine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma
×
Gels
×
Clear all
NCT03546166
2023-07-21
PICABAS
Centre Hospitalier Universitaire de Nice
Phase 2
Completed
24 enrolled